ClinicalTrials.gov
public full text
Public Domain
Antineoplaston Therapy in Treating Patients With Brain Stem Glioma
RATIONALE: Current therapies for a brain stem glioma provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of brain stem gliomas. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on children (\> 6 months of age) and adults with newly-diagnosed or recurrent brain stem gliomas.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma#1161306
- Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma#1094863
- Study of AG-120 and AG-881 in Subjects With Low Grade Glioma#1111560
- Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors#966361
- AMG 102 and Avastin for Recurrent Malignant Glioma#387232
Record · ID 1031971
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive